ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 190

$835K Total Retail Price of All Prescriptions

Rank: 5 out of 190

1,349 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 4,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
PAROXETINE HCL 2,358 932 10 1 4
TRAZODONE HCL 1,222 255 2 7
FLUOXETINE HCL 1,111 241 3 1
ZOLPIDEM TARTRATE 998 294 4 2
RISPERIDONE 977 278 5 5
BUPROPION HCL SR 522 58 6 17
DIVALPROEX SODIUM 517 63 7 14
QUETIAPINE FUMARATE 478 119 8 9
SERTRALINE HCL 437 125 9 3
CYMBALTA 405 37 10 10
CITALOPRAM HBR 339 131 11 6
ABILIFY 329 47 12 18
LITHIUM CARBONATE 267 20 13 27
SEROQUEL 257 64 14 22
BUPROPION XL 238 22 15 8
OLANZAPINE 180 72 16 19
ALPRAZOLAM 168 40 17 48
HALOPERIDOL 157 42 18 21
DONEPEZIL HCL 157 129 18 29
TEMAZEPAM 147 41 20 61
PRISTIQ ER 131 26 21 32
ESTAZOLAM 122 65 22 77
RANITIDINE HCL 116 47 23 37
ESCITALOPRAM OXALATE 114 20 24 33
ZALEPLON 109 32 25 56
BENZTROPINE MESYLATE 105 48 R 26 15
CLONAZEPAM 103 21 27 28
VENLAFAXINE HCL ER 101 38 28 13
CHLORPROMAZINE HCL 101 12 28 26
LAMOTRIGINE 90 19 30 24
NAMENDA 88 80 31 36
HYDROXYZINE PAMOATE 87 25 R 32 23
BUSPIRONE HCL 76 23 33 16
OMEPRAZOLE 69 20 34 43
LORAZEPAM 68 22 35 56
GABAPENTIN 61 23 36 38
BUDEPRION SR 60 16 37 52
DIVALPROEX SODIUM ER 55 0 38 31
THIORIDAZINE HCL 55 14 R 38 35
LUNESTA 53 0 40 66
LOSARTAN-HYDROCHLOROTHIAZIDE 53 38 40 94
SIMVASTATIN 52 41 42 80
SEROQUEL XR 52 14 42 34
DIPHENHYDRAMINE HCL 52 0 R 42 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.